Wang, J., Xiao, Y., Yu, Q., & Zhang, C. (2023). KRT72 might serves as a prognostic biomarker for patients with prostate cancer. Elsevier.
Chicago Style (17th ed.) CitationWang, Jie, Yuhan Xiao, Qingxin Yu, and Chi Zhang. KRT72 Might Serves as a Prognostic Biomarker for Patients with Prostate Cancer. Elsevier, 2023.
MLA (9th ed.) CitationWang, Jie, et al. KRT72 Might Serves as a Prognostic Biomarker for Patients with Prostate Cancer. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.